We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2057:HKEXZTO Express (Cayman) Inc. Analysis

Data as of 2026-03-14 - not real-time

HK$188.50

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

ZTO Express is trading well above its intrinsic estimate, with the market price comfortably exceeding the discounted cash‑flow fair value. The stock benefits from a solid earnings base, healthy operating margins and a dividend yield that outpaces many peers, while the payout ratio remains comfortably sustainable given strong cash generation. Technical signals show a bullish price trend above the short‑term moving averages, a supportive price level near the identified support zone and a modest upside potential toward the resistance line. However, the MACD histogram is in negative territory, suggesting short‑term momentum could soften ahead of the upcoming fourth‑quarter and full‑year earnings release.
The broader logistics sector in China carries medium regulatory and geographic exposure, yet ZTO’s low beta and stable trading volume mitigate systemic risk. Valuation metrics such as a price‑to‑earnings multiple well below the industry average and a dividend yield near three percent reinforce the case for a value‑oriented entry, while the company’s growth trajectory—driven by rising parcel volumes—supports a longer‑run growth narrative.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near short‑term support
  • MACD bearish momentum
  • upcoming earnings announcement

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • stable dividend yield
  • operating margins above industry norm
  • mid‑term price target within resistance range

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • consistent revenue growth from parcel volume expansion
  • low beta indicating defensive characteristics
  • fundamental value gap versus market price

Key Metrics & Analysis

Financial Health

Revenue Growth11.10%
Profit Margin18.60%
P/E Ratio15.3
ROE14.21%
ROA7.32%
Debt/Equity18.91
P/B Ratio2.0
Op. Cash FlowHK$10.5B
Free Cash FlowHK$2.5B
Industry P/E29.1

Technical Analysis

TrendBullish
RSI57.4
SupportHK$175.00
ResistanceHK$198.00
MA 20HK$187.66
MA 50HK$179.08
MA 200HK$156.56
MACDBearish
VolumeStable
Fear & Greed Index72.88

Valuation

Fair ValueHK$87.12
Target PriceHK$196.90
Upside/Downside4.45%
GradeOvervalued
TypeBlend
Dividend Yield2.68%

Risk Assessment

Beta0.15
Volatility27.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.